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Recent reports have suggested that women of
reproductive age in the United States may
have a higher exposure to flame retardants,
particularly polybrominated diphenyl ethers
(PBDEs) (Petreas et al. 2003; Schecter et al.
2003; She et al. 2002), than their counterparts
in European countries (Guvenius et al. 2003;
Sjödin et al. 1999, 2001b; Thomsen et al.
2001). In addition, studies from the United
States have shown that PBDE levels have
increased in recent decades (Petreas et al. 2003;
Sjödin et al. 2004b). Some evidence suggests
that these chemicals have the potential to affect
neurodevelopment and the endocrine system
in animals (Birnbaum and Staskal 2004;
Legler and Brouwer 2003). The route of expo-
sure in humans is thought to be through food,
ingestion of dust (Schecter et al. 2004; Sjödin
et al. 2004b, 2005), and by inhalation (Sjödin
et al. 1999, 2001a), but further study is
required to elucidate these pathways. 
In the present study we report the results
of PBDE measurements in a pilot study of
immigrant Mexican pregnant women. 
Materials and Methods
We selected a convenience sample of 24
women who participated in the Center for
the Health Assessment of Mothers and
Children of Salinas (CHAMACOS) project,
a longitudinal birth cohort study of 601 preg-
nant women living in the Salinas Valley,
California (Eskenazi et al. 2003). To be eligi-
ble, a women had to be enrolled in MediCal,
> 18 years of age, < 20 weeks gestation at
enrollment, and speak English or Spanish.
We obtained written informed consent from
participants before enrollment according to
procedures approved by the University of
California, Berkeley, Committee for the
Protection of Human Subjects. The serum
specimens analyzed in the current investiga-
tion were collected between September 1999
and January 2001. 
Women were interviewed twice during
pregnancy at approximately 13 and 26 weeks
gestational age to ascertain information on
demographic characteristics, lifestyle habits,
work history, and medical history. We also
administered a food frequency questionnaire
to each participant during the second inter-
view. Blood was collected in the third
trimester by venipuncture and immediately
processed in a clinical laboratory and frozen
at –80°C. Additional information about
blood sample collection and processing is pre-
sented by Eskenazi et al. (2003).







(BDE-183), as well as 2,2´,4,4´,5,5´-hexa-
chlorobiphenyl [polychlorinated biphenyl
(PCB)-153], and 2,2´,4,4´,5,5´-hexabromo-
biphenyl [polybrominated biphenyl (PBB)-
153] in plasma, and concentrations of target
analytes were expressed as nanograms per gram
lipid (weight of lipids). The plasma lipid con-
centration was determined enzymatically using
commercially available test kits from Roche
Diagnostics Corp. (Indianapolis, IN). For
PBDE, PCB-153, and PBB-153 analysis, we
extracted the samples according to Hovander
et al. (2000). In brief, the samples (0.6–3.6 g)
were fortiﬁed with 13C-labeled internal stan-
dards [750 pg/congener, except 2,2´,3,4,4´-
pentaBDE (BDE-85), for which no
13C-labeled standard existed (Cambridge
Isotope Laboratory, Andover, MA)]. The sam-
ples were thereafter denaturated with 6 mol/L
hydrochloric acid (1 mL) and 2-propanol
(6 mL) with mixing between each addition
and extracted with n-hexane/methyl-tert-butyl
ether (6 mL, 1:1 by volume) The organic layer
was isolated and the water phase reextracted
with additional solvent. The extracts were
then partitioned against potassium chloride
solution (1% by weight in water). The organic
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BACKGROUND: Recent studies have raised concerns about polybrominated diphenyl ether (PBDE)
flame retardant exposures to pregnant women and women of child-bearing age in the United
States. Few studies have measured PBDEs in immigrant populations. 
OBJECTIVES: Our goal was to characterize levels of seven PBDE congeners, polychlorinated
biphenyl (PCB)-153, and polybrominated biphenyl (PBB)-153 in plasma from 24 pregnant women
of Mexican descent living in an agricultural community in California.
RESULTS: The median concentration of the sum of the PBDE congeners was 21 ng/g lipid and
ranged from 5.3 to 320 ng/g lipid. Consistent with other studies, 2,2´,4,4´-tetrabromodiphenyl
ether (BDE-47) was found at the highest concentration (median = 11 ng/g lipid; range, 2.5–205)
followed by 2,2´,4,4´,5-pentabromobiphenyl (BDE-99) (median = 2.9 ng/g lipid; range, 0.5–54),
2,2´,4,4´,5-pentaBDE (BDE-100) (median = 1.8 ng/g lipid; range, 0.6–44), and 2,2´,4,4´,5,5´-
hexaBDE (BDE-153) (median = 1.5 ng/g lipid; range, 0.4–35). Levels of PCB-153 (median= 4.4
ng/g lipid; range, < 2–75) were lower than U.S. averages and uncorrelated with PBDE levels,
suggesting different exposure routes.
CONCLUSIONS: The overall levels of PBDEs found were lower than levels observed in other
U.S. populations, although still higher than those observed previously in Europe or Japan. The
upper range of exposure is similar to what has been reported in other U.S. populations. PBDEs
have been associated with adverse developmental effects in animals. Future studies are needed to
determine the sources and pathways of PBDE exposures and whether these exposures have adverse
effects on human health. 
KEY WORDS: blood, brominated flame retardant, exposure, Mexican, PBDE, polybrominated
diphenyl ethers, pregnant. Environ Health Perspect 115:71–74 (2007). doi:10.1289/ehp.8899
available via http://dx.doi.org/ [Online 19 October 2006]fraction was then evaporated to dryness. Co-
extracted lipids were removed on a silica/
silica:sulfuric acid column packed in a 3-mL
solid phase extraction cartridge (Sjödin et al.
2004a). We performed ﬁnal analytical deter-
mination of the target analytes using gas
chromatography isotope dilution high resolu-
tion mass spectrometry with a MAT95XP
(Thermo Electron, Bremen, Germany) instru-
ment (Sjödin et al. 2004a). Three blank and
three quality control (QC) samples (unforti-
ﬁed human serum) were included in every set
of 24 unknowns (Sjödin et al. 2004a). The
limit of detection (LOD) was deﬁned as three
times the standard deviation of the blank sam-
ples analyzed in parallel with the unknowns;
in the absence of a signal in the blank sam-
ples, the LOD was defined as 10 times the
signal-to-noise ratio. Because of the variable
sample size available (0.6–3.6 g), the calcu-
lated LOD depended on the sample size, and
ranged from 0.1 to 1 ng/g lipid. For all statis-
tical handling of the analytical data, all meas-
urements below the LOD were divided by the
square root of two. 
The coefficient of variance (CV) for 60
QC samples analyzed during a 9-month period
before and after the study specimens reported
on in this article were BDE-47 (3%); BDE-85
(10%), BDE-99 (4%), BDE-100 (4%), BDE-
153 (5%), BDE-154 (6%), BDE-183 (22%),
and PCB-153 (6%) (Sjödin et al. 2004a).
Statistical analysis of the PBDE measure-
ments included computation of descriptive sta-
tistics for individual congeners as well as a
measure of total exposure to PBDEs (sum of
all congeners—BDE-47, BDE-85, BDE-99,
BDE-100, BDE-153, BDE-154, and BDE-
183). We calculated Spearman correlation
coefﬁcients between individual congeners and
between PBDE levels and years participants
had lived in the United States. Because
BDE-99 and BDE-47 are the most commonly
detected PBDEs with the highest concentra-
tions, we further evaluated the ratio of
BDE-99 to BDE-47 to determine whether this
ratio changed over time. Temporal changes in
this ratio can provide insight about exposure
patterns because their ratio in the environment
is known and they have different half-lives in
humans. Finally, we used the Fischer’s exact
test of the proportion above and below the
population median to compare levels by demo-
graphic characteristics (STATA Median Test;
StataCorp 2001). All statistical analyses were
conducted using STATA (StataCorp 2001).
Results
The levels and distributions for the seven
PBDE congeners are presented in Table 1.
The total PBDE levels ranged from 5.3 to
320 ng/g lipid, with BDE-47 as the dominant
congener. All levels for BDE-47, BDE-99,
BDE-100, and BDE-153 were above the
LOD. All the PBDE congeners were moder-
ately to strongly correlated with each other
(Spearman rho = 0.53–0.95, p < 0.05) whereas
no significant correlation between PCB-153
and PBB-153 and the PBDE congeners were
observed. BDE-183 was excluded from these
correlation calculations because > 75% of the
measurements were below the LOD (Table 2).
The concentration of the sum of PBDEs in
two participants exceeded 100 ng/g lipid (8%
of the subjects), a proportion similar to that of
other studies. (Morland et al. 2005; Schecter
et al. 2005). 
Table 3 shows selected demographic char-
acteristics of the subjects. Women were on aver-
age (± SD) 26 ± 4.8 years of age, overweight,
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Table 1. Concentration (ng/g lipid) of measured PBDEs, PBBs, and PCBs in selected samples (n = 24) from
a cohort of pregnant Latina women in California.
Detection Selected Percentilesa
Compound frequency (%) LODb Minimum 25th 50th 75th Maximum
PBDEs
BDE-47 100 — 2.5 7.6 11 21 205
BDE-85 71 0.2–1 < 0.1b < 0.1b 0.3 0.5 5.0
BDE-99 100 — 0.5 1.9 2.9 4.5 54
BDE-100 100 — 0.6 1.2 1.8 3.2 44
BDE-153 100 — 0.4 0.9 1.5 2.8 35
BDE-154 75 0.2–0.5 < 0.1b < 0.2b 0.3 0.4 4.2
BDE-183 33 0.1–0.5 < 0.1b < 0.1b < 0.1b 0.4 39
Sum of PBDEs 100 — 5.3 13 21 34 320
PCBs and PBBs
PCB-153 96 2 < 2b 2.8 4.4 6.6 75
PBB-153 38 0.2–1 0.1 0.2 0.2 0.4 1.5
aPercentiles calculated based on results for all (n = 24) samples. bThe calculated LOD varied by sample due to variable
sample sizes (0.6–3.6 g); for all statistical analyses, all measurements below the LOD were divided by the square root of two.
Table 2. Spearman’s rank-order correlation coefficients between individual PBDE congeners and
PCB-153. 
Compound BDE-47 BDE-85 BDE-99 BDE-100 BDE-153 BDE-154
BDE-85 0.91**
BDE-99 0.92** 0.92**
BDE-100 0.95** 0.88** 0.86**
BDE-153 0.6** 0.62** 0.53** 0.75**
BDE-154 0.58** 0.69** 0.66** 0.65** 0.77**
PCB-153 0.13 0.17 0.16 0.15 0.09 0.06
Years in United States 0.35 0.19 0.19 0.49* 0.44* 0.25
*p < 0.05; **p < 0.01.
Table 3. Demographic characteristics of study participants (n = 24) and relationship with BDE-47 and total
PBDEs (ng/g lipids).
Characteristic No. (%) BDE-47 (median) Total PBDEs (median)
Age (years)
≤ 25 12 (50) 11.3 20.8
> 25 12 (50) 12.2 20.4
Years in United States
< 5  14 (58) 10.0 18.7
≥ 5 10 (42) 14.5 22.9
Parity
0 10 (42) 11.3 18.7
≥ 1 14 (58) 12.2 22.6
Previous lactation (months, parous women only) 
< 12 6 (43) 12.2 19.4
≥ 12 8 (57) 12.5 27.7
Agricultural work
None 6 (26) 7.1 14.2
Farm 17 (74) 14.4 23.0
BMI 
Under/normal 10 (42) 10.7 18.7
Over/obese 14 (58) 14.3 22.6
Fish consumption (servings)
< 1/month 14 (61) 14.7 22.6
≥ 1/month 9 (39) 10.1 17.8
Dairy consumption (servings)
< 2.3/day 12 (50) 11.3 18.7
≥ 2.3/day 12 (50) 12.3 22.6
Total fat (g)
< 113/day 12 (50) 12.8 21.3
≥ 113/day 12 (50) 9.5 20.0and multiparous with a previous history of
lactation. All women were of Mexican descent.
Twenty-three were born in Mexico and one in
the United States, with more than half having
lived in the United States < 5 years (average
5.7 ± 6.9 years). More than half were field
workers, and an additional 17% worked in
other areas of agriculture. 
Few of the demographic characteristics
were associated with total PBDE levels or with
levels of BDE-47. Overall, levels of PBDE
were slightly higher, albeit nonsigniﬁcantly, in
those women who were agricultural workers,
who had a higher body mass index (BMI),
and, paradoxically, among parous women
with more months of previous lacation (total
PBDEs only). We also observed lower levels of
PBDEs, in women who consumed more than
one serving of ﬁsh per month or > 113 g fat/
day as compared to women who consumed
less. The small sample size limits the interpre-
tation of these comparisons. The correlations
of total PBDE and BDE-47 with number of
years living in the United States were not sig-
niﬁcant at a cut-off of p < 0.05 (Spearman rho
= 0.35, p = 0.08; and rho = 0.38, p = 0.06,
respectively). After excluding the two highest
values for participants living in the United
States for 2 and 6 years, respectively, the corre-
lations decreased < 0.1 with p > 0.5 (Figure 1).
BDE-100 and BDE-153 were moderately cor-
related with years in the United States
(Spearman rho = 0.49 and 0.44, respectively)
(Table 2). Overall, most Spearman correla-
tions were positive, suggesting that levels
increased with time in the United States and
might have been significant had the sample
size been larger. Levels of PCB-153 (median =
4.4 ng/g lipid, range, < 2–75) were lower than
U.S. averages and uncorrelated with PBDE
levels (Table 2).
The median ratio of BDE-99 to BDE-47
in our sample was 0.23, with a maximum of
0.47. Figure 2 presents a scatterplot of the
ratio of BDE-99 to BDE-47 by the number of
years the women had been in the United
States. The ratios are highest among women
who have spent < 5 years in the United States
compared to women who have spent > 5 years
in the United States (Spearman rho = –0.59,
p < 0.01). 
Discussion 
This pilot study indicates that women of
Mexican origin living in a California agricul-
tural community were exposed to PBDEs.
The small sample size limits our ability to
determine which factors are associated with
these exposures. Preliminary analyses suggest
that there were no clear associations of demo-
graphic characteristics including age, lactation,
and parity with blood levels of PBDEs. The
data suggest that PBDE levels are somewhat
higher in women with higher body mass, who
had lower ﬁsh consumption, who worked in
agriculture, and, paradoxically, among parous
women with more months of previous laca-
tion (total PBDEs only). 
Only one previous study in the United
States was conducted in an immigrant popu-
lation (Petreas et al. 2003). In that study of
women from Southeast Asia, only BDE-47
was measured, and 52% of the women’s
BDE-47 levels were not detectable due to
high detection limits. The median BDE-47
level in the South Asian women was 10 ng/g
lipid (range, < 10–511) and comparable to
our cohort of Mexican immigrants having a
median BDE-47 level of 11 ng/g lipid (range,
2.5–205) but lower than that reported for a
cohort of women from California (median =
18 ng/g lipid; range, 7.01–196) (She et al.
2002). Similar to our findings, Petreas and
coauthors (2003) did not ﬁnd a positive asso-
ciation between PBDE levels and age. This
lack of an increase with age is in contrast to
other persistent organic pollutants and
has been previously reported for PBDEs
(Darnerud et al. 2001). 
The median BDE-99/BDE-47 ratio of
0.23 in our data is consistent with that of pre-
vious human studies (Morland et al. 2005;
Schecter et al. 2005; She et al. 2002) and
reflects a normal metabolized congener pat-
tern that is different from the pattern found in
indoor dust and technical pentaBDE (a ratio
generally greater than one). The lower level of
BDE-99 compared to BDE-47 in biologic
samples could be caused by the shorter half-
life of BDE-99 relative to BDE-47 and also
suggests that no contamination of our samples
by exogenous PBDEs, which have a higher
ratio (Sjödin et al. 1998, 2005), occurred dur-
ing sample collection and handling. We also
report that the ratio of BDE-99 to BDE-47
was higher in women who recently immi-
grated to the United States (Figure 2). We
have no ready explanation for this finding.
One possibility is that the women may have
experienced lower exposures to PBDEs from
indoor dust in their home country than in the
United States. At least compared to Europe,
house dust in the United States contains high
levels of PBDE congeners found in commer-
cial pentaBDE, including BDE-99 and
BDE-47 in ratios close to unity. For example,
the indoor dust concentration of BDE-47 in
Germany has been reported to be < 14–22
ng/g versus 230–3,000 ng/g reported in the
United States (Sjödin et al. 2005). No data are
available on PBDE levels in residential envi-
ronments in Mexico; however, overall use is
negligible compared to the United States
(Hale et al. 2003), suggesting that residential
environmental contamination is likely to be
low. Thus, on arrival in the United States, the
women likely experienced exposures to dust
with a higher PBDE concentration. Because
BDE-99 is less persistent in humans, the ratio
in our participants possibly decreased over
time as BDE-99 was excreted and BDE-47
was retained. It is also possible that continued
exposure from other environmental or dietary
sources and bioaccumulation of BDE-47
altered the relative balance of these congeners
over time.
The high degree of correlation between
the different PBDE congeners analyzed and
the complete absence of correlation between
the PBDE congeners and PCB-153 (Table 2)
may suggest that the exposure routes for these
two classes of compounds are different. It is
well known that humans are exposed to PCBs
to a large extent though dietary sources
(Patandin et al. 1999). Hence, the absence of
correlation between PCB-153 and the PBDEs
may indicate that nondietary pathways are of
greater importance for PBDEs, a ﬁnding con-
sistent with data recently reported by Schecter
et al. (2006). 
Our study provides data on PBDE levels
in a Mexican population living in a U.S. agri-
cultural community. The overall levels of
PBDE found in this study were slightly lower
than levels observed in other U.S. populations,
although the upper range of exposure is simi-
lar. Nevertheless, these levels were higher than
those observed previously in Europe or Japan
(Hites 2004). As in previous U.S. studies
PBDEs in pregnant Latina women
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Figure 1. Scatterplot of BDE-47 concentration (ng/g
lipid) by years resided in the United States (n = 24).
BDE-47 and number of years lived in the United
States were not signiﬁcantly correlated.


























Figure 2. Scatterplot of the ratio of BDE-99 to
BDE-47 by years resided in the United States (n =
24). The ratios are highest among women who had
spent < 5 years in the United States compared with
women who had spent > 5 years in the United States
(Spearman rho = –0.59, p < 0.01). 


























7(Hites 2004), we found that the congener
with the highest levels was BDE-47. PBDEs
have been shown to cause adverse develop-
mental effects in animal experiments (Eriksson
et al. 2001; McDonald 2005; Viberg et al.
2003). Future studies should determine the
sources and pathways of PBDE exposures and
whether these exposures have adverse impacts
on human neurodevelopment.
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